A
$ Value
$0
Shares
35,156
Price
$0
Filed
Aug 25
Insider
Name
Greco Theresa
Title
Chief Commercial Officer
CIK
0001998771
Roles
Officer
Transaction Details
Transaction Date
2025-08-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
35,156
Footnotes
Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date. | The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
Filing Info
Greco Theresa's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-23 | OPRX | F | $18K |
| 2025-11-01 | OPRX | F | $35K |
| 2025-08-21 | OPRX | A | $0 |
| 2025-08-21 | OPRX | A | $0 |
| 2025-05-15 | OPRX | A | $0 |
| 2025-05-15 | OPRX | A | $0 |
| 2025-05-15 | OPRX | A | $0 |
Other Insiders at OPRX (90d)
No other insider activity at this issuer in the last 90 days.